Encompass Health Corp Stock Alpha and Beta Analysis
| EHC Stock | USD 95.98 2.30 2.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Encompass Health Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Encompass Health over a specified time horizon. Remember, high Encompass Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Encompass Health's market risk premium analysis include:
Beta 0.63 | Alpha (0.05) | Risk 1.3 | Sharpe Ratio (0.05) | Expected Return (0.06) |
Encompass Health Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Encompass |
Encompass Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Encompass Health market risk premium is the additional return an investor will receive from holding Encompass Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Encompass Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Encompass Health's performance over market.| α | -0.05 | β | 0.63 |
Encompass Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Encompass Health's Buy-and-hold return. Our buy-and-hold chart shows how Encompass Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Encompass Health Market Price Analysis
Market price analysis indicators help investors to evaluate how Encompass Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Encompass Health shares will generate the highest return on investment. By understating and applying Encompass Health stock market price indicators, traders can identify Encompass Health position entry and exit signals to maximize returns.
Encompass Health Return and Market Media
The median price of Encompass Health for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 98.01 with a coefficient of variation of 3.48. The daily time series for the period is distributed with a sample standard deviation of 3.38, arithmetic mean of 97.1, and mean deviation of 2.98. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 2446 shares by Andrew Price of Encompass Health at 92.35 subject to Rule 16b-3 | 12/31/2024 |
2 | Reinhart Partners LLC. Has 60.61 Million Stake in Encompass Health Co. - MarketBeat | 01/13/2025 |
| Encompass Health dividend paid on 15th of January 2025 | 01/15/2025 |
3 | Acquisition by Christie Edward M Iii of 292 shares of Encompass Health at 94.4 subject to Rule 16b-3 | 01/16/2025 |
4 | Encompass Health Named One of Fortunes Worlds Most Admired Companies for Fifth Consecutive Year | 02/05/2025 |
5 | Encompass Health Q4 Earnings Beat on Strong Discharge Growth | 02/11/2025 |
6 | Encompass Health opens new hospital in Georgia | 02/19/2025 |
7 | Encompass Health Declares US0.17 Quarterly Dividend Payable April 15 2025 | 02/20/2025 |
8 | Encompass Health Corp Declares Quarterly Dividend | 02/21/2025 |
9 | Disposition of 401 shares by Andrew Price of Encompass Health at 97.53 subject to Rule 16b-3 | 02/24/2025 |
10 | Disposition of 410 shares by Andrew Price of Encompass Health at 100.63 subject to Rule 16b-3 | 02/25/2025 |
11 | Are You a Value Investor This 1 Stock Could Be the Perfect Pick | 02/26/2025 |
12 | Disposition of 304 shares by Andrew Price of Encompass Health at 100.14 subject to Rule 16b-3 | 02/28/2025 |
13 | Encompass Health Full Year 2024 Earnings EPS Beats Expectations | 03/04/2025 |
14 | Disposition of 416 shares by John Darby of Encompass Health at 100.14 subject to Rule 16b-3 | 03/06/2025 |
15 | Raymond James Financial Inc. Acquires New Holdings in Encompass Health Co. | 03/10/2025 |
About Encompass Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Encompass or other stocks. Alpha measures the amount that position in Encompass Health Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0167 | 0.009098 | 0.006807 | 0.006467 | Price To Sales Ratio | 1.36 | 1.38 | 1.72 | 2.49 |
Encompass Health Upcoming Company Events
As portrayed in its financial statements, the presentation of Encompass Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encompass Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Encompass Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Encompass Health. Please utilize our Beneish M Score to check the likelihood of Encompass Health's management manipulating its earnings.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Encompass Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Encompass Health Backtesting, Encompass Health Valuation, Encompass Health Correlation, Encompass Health Hype Analysis, Encompass Health Volatility, Encompass Health History and analyze Encompass Health Performance. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Encompass Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.